Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells

Background/Aim:We have demonstrated that exogenous hydrogen sulfide (H2S) protects H9c2 cardiac cells against the doxorubicin (DOX)-induced injuries by inhibiting p38 mitogen-activated protein kinase (MAPK) pathway and that the p38 MAPK/nuclear factor-κB (NF-κB) pathway is involved...

Full description

Bibliographic Details
Main Authors: Runmin Guo, Keng Wu, Jingfu Chen, Liqiu Mo, Xiaoxiao Hua, Dongdan Zheng, Peixi Chen, Gang Chen, Wenming Xu, Jianqiang Feng
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2013-12-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/356602
id doaj-65f60cd395984e2682b0bf194d9cf517
record_format Article
spelling doaj-65f60cd395984e2682b0bf194d9cf5172020-11-25T02:46:35ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782013-12-013261668168010.1159/000356602356602Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac CellsRunmin GuoKeng WuJingfu ChenLiqiu MoXiaoxiao HuaDongdan ZhengPeixi ChenGang ChenWenming XuJianqiang FengBackground/Aim:We have demonstrated that exogenous hydrogen sulfide (H2S) protects H9c2 cardiac cells against the doxorubicin (DOX)-induced injuries by inhibiting p38 mitogen-activated protein kinase (MAPK) pathway and that the p38 MAPK/nuclear factor-κB (NF-κB) pathway is involved in the DOX-induced inflammatory response and cytotoxicity. The present study attempts to test the hypothesis that exogenous H2S might protect cardiomyocytes against the DOX-induced inflammation and cytotoxicity through inhibiting p38 MAPK/NF-κB pathway. Methods: H9c2 cardiac cells were exposed to 5µM DOX for 24 h to establish a model of DOX cardiotoxicity. The cells were pretreated with NaHS( a donor of H2S) or other drugs before exposure to DOX. Cell viability was analyzed by cell counter kit 8 ( CCK-8), The expression of NF-κB p65 and inducible nitric oxide synthase (iNOS) was detected by Western blot assay. The levels of interleukin-1ß (IL-1ß), IL-6 and tumor necrosis factor-a (TNF-a) were tested by enzyme-linked immunosorbent assay (ELISA). Results: Our findings demonstrated that pretreatment of H9c2 cardiac cells with NaHS for 30 min before exposure to DOX markedly ameliorated the DOX-induced phosphorylation and nuclear translocation of NF-κB p65 subunit. Importantly, the pretreatment with NaHS significantly attenuated the p38 MAPK/NF-κB pathway-mediated inflammatory responses induced by DOX, as evidenced by decreases in the levels of IL-1ß, IL-6 and TNF-a. In addition, application of NaHS or IL-1ß receptor antagonist (IL-1Ra) or PDTC (an inhibitor of NF-κB) attenuated the DOX-induced expression of iNOS and production of nitric oxide (NO), respectively. Furthermore, IL-1Ra also dramatically reduced the DOX-induced cytotoxicity and phosphorylation of NF-κB p65. The pretreatment of H9c2 cells with N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS) prior to exposure to DOX depressed the phosphorylation of NF-κB p65 induced by DOX. Conclusion: The present study has demonstrated the new mechanistic evidence that exogenous H2S attenuates the DOX-induced inflammation and cytotoxicity by inhibiting p38 MAPK/NF-κB pathway in H9c2 cardiac cells. We also provide novel data that the interaction between NF-κB pathway and IL-1ß is important in the induction of DOX-induced inflammation and cytotoxicity in H9c2 cardiac cells.http://www.karger.com/Article/FullText/356602Hydrogen sulfideDoxorubicinNuclear factor-κBCardiotoxicityInflammationp38 mitogen-activated protein kinases
collection DOAJ
language English
format Article
sources DOAJ
author Runmin Guo
Keng Wu
Jingfu Chen
Liqiu Mo
Xiaoxiao Hua
Dongdan Zheng
Peixi Chen
Gang Chen
Wenming Xu
Jianqiang Feng
spellingShingle Runmin Guo
Keng Wu
Jingfu Chen
Liqiu Mo
Xiaoxiao Hua
Dongdan Zheng
Peixi Chen
Gang Chen
Wenming Xu
Jianqiang Feng
Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
Cellular Physiology and Biochemistry
Hydrogen sulfide
Doxorubicin
Nuclear factor-κB
Cardiotoxicity
Inflammation
p38 mitogen-activated protein kinases
author_facet Runmin Guo
Keng Wu
Jingfu Chen
Liqiu Mo
Xiaoxiao Hua
Dongdan Zheng
Peixi Chen
Gang Chen
Wenming Xu
Jianqiang Feng
author_sort Runmin Guo
title Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
title_short Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
title_full Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
title_fullStr Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
title_full_unstemmed Exogenous Hydrogen Sulfide Protects against Doxorubicin-Induced Inflammation and Cytotoxicity by Inhibiting p38MAPK/NFκB Pathway in H9c2 Cardiac Cells
title_sort exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38mapk/nfκb pathway in h9c2 cardiac cells
publisher Cell Physiol Biochem Press GmbH & Co KG
series Cellular Physiology and Biochemistry
issn 1015-8987
1421-9778
publishDate 2013-12-01
description Background/Aim:We have demonstrated that exogenous hydrogen sulfide (H2S) protects H9c2 cardiac cells against the doxorubicin (DOX)-induced injuries by inhibiting p38 mitogen-activated protein kinase (MAPK) pathway and that the p38 MAPK/nuclear factor-κB (NF-κB) pathway is involved in the DOX-induced inflammatory response and cytotoxicity. The present study attempts to test the hypothesis that exogenous H2S might protect cardiomyocytes against the DOX-induced inflammation and cytotoxicity through inhibiting p38 MAPK/NF-κB pathway. Methods: H9c2 cardiac cells were exposed to 5µM DOX for 24 h to establish a model of DOX cardiotoxicity. The cells were pretreated with NaHS( a donor of H2S) or other drugs before exposure to DOX. Cell viability was analyzed by cell counter kit 8 ( CCK-8), The expression of NF-κB p65 and inducible nitric oxide synthase (iNOS) was detected by Western blot assay. The levels of interleukin-1ß (IL-1ß), IL-6 and tumor necrosis factor-a (TNF-a) were tested by enzyme-linked immunosorbent assay (ELISA). Results: Our findings demonstrated that pretreatment of H9c2 cardiac cells with NaHS for 30 min before exposure to DOX markedly ameliorated the DOX-induced phosphorylation and nuclear translocation of NF-κB p65 subunit. Importantly, the pretreatment with NaHS significantly attenuated the p38 MAPK/NF-κB pathway-mediated inflammatory responses induced by DOX, as evidenced by decreases in the levels of IL-1ß, IL-6 and TNF-a. In addition, application of NaHS or IL-1ß receptor antagonist (IL-1Ra) or PDTC (an inhibitor of NF-κB) attenuated the DOX-induced expression of iNOS and production of nitric oxide (NO), respectively. Furthermore, IL-1Ra also dramatically reduced the DOX-induced cytotoxicity and phosphorylation of NF-κB p65. The pretreatment of H9c2 cells with N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS) prior to exposure to DOX depressed the phosphorylation of NF-κB p65 induced by DOX. Conclusion: The present study has demonstrated the new mechanistic evidence that exogenous H2S attenuates the DOX-induced inflammation and cytotoxicity by inhibiting p38 MAPK/NF-κB pathway in H9c2 cardiac cells. We also provide novel data that the interaction between NF-κB pathway and IL-1ß is important in the induction of DOX-induced inflammation and cytotoxicity in H9c2 cardiac cells.
topic Hydrogen sulfide
Doxorubicin
Nuclear factor-κB
Cardiotoxicity
Inflammation
p38 mitogen-activated protein kinases
url http://www.karger.com/Article/FullText/356602
work_keys_str_mv AT runminguo exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT kengwu exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT jingfuchen exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT liqiumo exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT xiaoxiaohua exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT dongdanzheng exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT peixichen exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT gangchen exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT wenmingxu exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
AT jianqiangfeng exogenoushydrogensulfideprotectsagainstdoxorubicininducedinflammationandcytotoxicitybyinhibitingp38mapknf954bpathwayinh9c2cardiaccells
_version_ 1724757280020234240